Detected ·

Caldera Therapeutics

$278M—

Caldera Therapeutics announced a merger with Synlogic alongside an upsized private placement expected to generate approximately $278M in gross proceeds to advance its lead bispecific antibody CLD-423 through Phase 2 trials.

Amount
$278 000 000 USD
Stage
—
Event
Funding round
Detected
2026-09-24 04:15:38 UTC
Signal ID
22b587ef-03bf-4208-85b3-9c27213a8232

As the API returns it

{
  "id": "22b587ef-03bf-4208-85b3-9c27213a8232",
  "created_at": "2026-09-24T04:15:38.789029Z",
  "company_name": "Caldera Therapeutics",
  "company_website_url": "www.calderatx.com",
  "company_linkedin_url": "https://www.linkedin.com/company/caldera-therapeutics",
  "event_type": "funding",
  "funding_amount": 278000000,
  "funding_currency": "USD",
  "funding_stage": null,
  "message": "*Caldera Therapeutics announced a merger with Synlogic alongside an upsized private placement expected to generate approximately $278M in gross proceeds to advance its lead bispecific antibody CLD-423 through Phase 2 trials.*"
}

Latest rounds